LifeSci Communications Fierce Pharma Asia—Takeda's Anima mRNA translation pact, China digital health incubator; Daiichi's COVID-19 vaccine

Takeda penned a potentially billion-dollar deal with Anima Biotech to work on mRNA translation modulators for neurological diseases. The Japanese pharma als

Press Releases - Media - Daiichi Sankyo

Anima signs new strategic collaboration deal with Takeda

Daiichi Sankyo applies for approval of mRNA COVID vaccine The Asahi Shimbun: Breaking News, Japan News and Analysis

World's First Inhalable COVID-19 Vaccine Approved in China - COVID-19 - mobile.

Fierce Pharma Asia—Takeda's Anima mRNA translation pact, China digital health incubator; Daiichi's COVID-19 vaccine

PharmaCompass – Grow Your Pharma Business Digitally

JCI - Article_in_issue

PharmaCompass – Grow Your Pharma Business Digitally

Japan panel endorses first domestically developed COVID vaccine - The Japan Times

Ned Pagliarulo BioPharma Dive

Sponsor Detail Template – Chinese American Biopharmaceutical Society

China's CanSinoBIO H1 revenue drops on weaker COVID shot demand

A Chinese mRNA COVID vaccine is approved for the first time - in Indonesia

World's First Inhalable COVID-19 Vaccine Approved in China - COVID-19 - mobile.